LivaNova PLC Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by LivaNova PLC on October 8, 2024. The report discloses the appointment of a new director to the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance rather than financial performance.
Material Changes
The primary material change is the appointment of Susan Podlogar to the Board of Directors and as a member of the Compensation and Human Capital Management Committee, effective October 8, 2024.
Management Commentary and Compensation
Ms. Podlogar brings over 30 years of experience, including roles as Executive Vice President and Chief Human Resources Officer at MetLife and various leadership positions at Johnson & Johnson. Her compensation package includes:
- Annual board retainer fee: $60,000
- Compensation and Human Capital Management Committee annual member fee: $8,000
- Annual service-based restricted stock award grant with a fair market value of $180,000
All compensation is prorated for her service with respect to fiscal 2024. The filing states there are no undisclosed arrangements or transactions involving Ms. Podlogar.
Investor Verification Checklist
- Verify the effective date of Ms. Podlogar's board appointment (October 8, 2024).
- Confirm the specific prorated compensation amounts for the remainder of fiscal 2024.
- Review the full Remuneration Policy to understand the terms of the restricted stock award.
- Check for any subsequent filings regarding the composition of the Compensation and Human Capital Management Committee.